Joel Morales became Chief Financial Officer at Alvogen in September 2017.  Before joining Alvogen, he worked for Endo International plc, where he was SVP of the Generics Business Segment and Global Finance Operations.  He was also responsible for a number of enterprise-wide strategic initiatives in direct support of the CEO and Executive Leadership Team. Prior to joining Endo, he worked for Merck & Co. and Schering-Plough, where he spent 10 years in various leadership roles, including the Corporate Strategy Office, Business Development and International Finance. Joel began his career with KPMG LLP, and is a licensed certified public accountant in the State of New Jersey.  He obtained his Bachelor of Science degree in accounting from Rutgers University. Joel Morales became Chief Financial Officer at Alvogen in September 2017.  Before joining Alvogen, he worked for Endo International plc, where he was SVP of the Generics Business Segment and Global Finance Operations.  He was also responsible for a number of enterprise-wide strategic initiatives in direct support of the CEO and Executive Leadership Team. Prior to joining Endo, he worked for Merck & Co. and Schering-Plough, where he spent 10 years in various leadership roles, including the Corporate Strategy Office, Business Development and International Finance. Joel began his career with KPMG LLP, and is a licensed certified public accountant in the State of New Jersey.  He obtained his Bachelor of Science degree in accounting from Rutgers University.

Pharmacology